Hearscape
← Devices & Neurotechnology
Details checkedStrong evidenceCheckedcompany

Oticon Medical Sentio System

Also known as: Sentio, Sentio System, Sentio Ti Implant, Sentio 1 Mini

Oticon Medical

Primary source
Company
Oticon Medical
Program Type
Device
Modality
Bone Conduction Implant
Stage
Marketed
Status
Marketed
Target Gene
—
Route / Mode
Active transcutaneous bone conduction implant and external sound processor
Confidence
86%
Status Confidence
Status confirmed
Evidence Strength
Strong evidence
Last Reviewed
2026-06-10
Geography
United States, Europe
Population
adult, pediatric, conductive, mixed-hearing-loss, unilateral
Trial IDs
0
Mechanism

Active transcutaneous bone conduction system combining the Sentio Ti implant with the Sentio 1 Mini sound processor held magnetically over the implant.

Indications
Conductive Hearing LossMixed Hearing LossSingle-Sided DeafnessHearing Loss
Notes

Important active transcutaneous bone-conduction platform and a useful comparator to Cochlear Osia and MED-EL BONEBRIDGE.

Evidence & Sources
3 structured sources
company
Supports: canonicalName, aliases, company, programType, modality, mechanism, status, route
Open
company
Supports: indications, populationTags, notes
Open
publication
Supports: notes
Open
Key Events
2024-09-01
Oticon Medical introduced Sentio as an active transcutaneous bone anchored hearing system
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed